tirzepatide osa approval FDA Approves (Zepbound) as the First Medication for Obstructive Sleep Apnea What clinicians should know about

Our experienced providers will help you choose the safest and most effective option for your individual needs

This fee encompasses evaluation by a licensed Nurx medical provider, a personalized treatment plan, regular check-ins, and prescription medication delivery with free shipping

Clinical studies show that patients may achieve an average weight loss of up to 26% of their body weight after sustained treatment

Eating large portions, high-fat meals, or consuming food too quickly can exacerbate symptoms, as the stomach struggles to process its contents at the usual rate

They should have a system in place to quickly notify patients of any safety issues

Patients experiencing significant side effects may benefit from a slower titration schedule or temporary dose reduction, and dose escalation should be deferred while significant gastrointestinal symptoms persist